Key Statistics
Market Cap$92.99M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.28
52W High$5.55
52W Low$0.83
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees56
Price Performance
1 Week+12.98%
3 Month+22.31%
1 Year+58.20%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$173.73M
Liabilities$48.02M
Net Income$73.79M loss
About
Pyxis Oncology, Inc., a preclinical biotechnology company, is dedicated to developing antibody-drug conjugate (ADC) and monoclonal antibody (mAb) immunotherapies for treating cancers. The company is headquartered in Cambridge, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze PYXS with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.